Medical Device Registration in Russia. The Essentials

Webinar: Successful Medical Device Registration in Russia. The Essentials

The current national system for Medical Device registration in Russia was created from scratch and entered into force in 2013. Most experts agree that this system is complex and puzzling – some critical points are not well documented, some regulatory requirements are ambiguous and unwritten rules play an essential role during the process.

 

The purpose of this webinar is to explain the Medical Device registration procedure in Russia.

 

You will learn about:

  1. Russian Competent Authorities in the medical device field
  2. State Legislation and levels of legislation
  3. The scheme of State registration
  4. The registration dossier and list of the documents
  5. Testing and evaluation (technical, toxicological, clinical)
  6. Post-registration activity
  7. Role of an Authorized Representative of the manufacturer

 

Expanding into the Russian market?

Make use of our experts to guide you from the start to a full market access. Explore your options in a chat with one of our experts.

Who should attend? Professionals from Medical Device companies working within:

  • Regulatory
  • R&D
  • QA/QC
  • Compliance
  • Product Development
  • Manufacturing

Duration: 50 min.

Speaker: Regulatory Affairs Project Manager, Mikhail Vinogradov, LLM, who will share his experience on registering Medical Devices in Russia.

Mikhail Vinogradov, LLM

Mikhail Vinogradov, LLM

Regulatory Affairs Project Manager

Other content that might interest you:

Marketing Authorization Process in Russia

Marketing Authorization Process in Russia

Cultural and language problems are a frequent stumbling block for multinational corporations seeking to register drugs in Russia. Additionally, the Marketing Authorization process in Russia is highly complex, and the paperwork frequently changes as the regulatory...

read more
Drug Registration in Russia

Drug Registration in Russia

 Overview of drug registration in Russia The Russian pharmaceutical industry is expected to exceed two trillion Russian rubles in 2020, representing a roughly 10% growth over the previous year. Pharmaceutical revenues are expected to reach 2.35 trillion Russian rubles...

read more

Big Enough To Cover  All Your Needs. Small Enough To Care.

Discover the tailored solutions that Biomapas provides to accelerate your clinical trials and optimize your drug development process.

Clinical Research

Regulatory Affairs

Pharmacovigilance

Medical Information